Literature DB >> 18230910

Relationship between metabolic syndrome and uterine leiomyomas: a case-control study.

Takashi Takeda1, Masahiro Sakata, Aki Isobe, Asako Miyake, Fumihito Nishimoto, Yukinobu Ota, Shouji Kamiura, Tadashi Kimura.   

Abstract

BACKGROUND/AIMS: Uterine leiomyomas are the most common gynecological benign tumor and greatly affect reproductive health and well-being. The pathophysiology and epidemiology of fibroids are poorly understood. Obesity and elevated blood pressure have been reported to be predisposing factors. In this study, we investigated whether fibroids are associated with some criteria of the metabolic syndrome.
METHODS: The case patients were 213 women who underwent hysterectomy or myomectomy for fibroids, and the control subjects were 159 women who underwent operation for benign indications other than fibroids. Preoperative information on body mass index (BMI), blood pressure (BP), serum triglyceride (TG) and fasting plasma glucose (FPG) was obtained from medical records. The patients were classified as overweight if they had a preoperatively measured BMI of > or =24.0, hypertensive if BP was > or =140/90 mm Hg, hypertriglyceridemic if TG was > or =150 mg/dl, and hyperglycemic if FPG was > or =110 mg/dl.
RESULTS: BMI, BP, TG and FPG were significantly higher in the case group compared with the control group. In logistic regression analysis, fibroids were statistically significantly associated with being overweight and hypertensive. With the combination of these risk factors, the risk of fibroids increased.
CONCLUSION: Uterine leiomyomas may share pathogenic features with the development of metabolic syndrome. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18230910     DOI: 10.1159/000114250

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  29 in total

1.  Uterine leiomyomata in a cohort of Great Lakes sport fish consumers.

Authors:  Anissa Lambertino; Mary Turyk; Henry Anderson; Sally Freels; Victoria Persky
Journal:  Environ Res       Date:  2011-02-09       Impact factor: 6.498

2.  BET1L and TNRC6B associate with uterine fibroid risk among European Americans.

Authors:  Todd L Edwards; Kara A Michels; Katherine E Hartmann; Digna R Velez Edwards
Journal:  Hum Genet       Date:  2013-04-19       Impact factor: 4.132

3.  Hypertension and risk of uterine leiomyomata in US black women.

Authors:  R G Radin; L Rosenberg; J R Palmer; Y C Cozier; S K Kumanyika; L A Wise
Journal:  Hum Reprod       Date:  2012-02-26       Impact factor: 6.918

4.  Effects of insulin resistance on myometrial growth.

Authors:  Zhi-Min Hou; Qian Sun; Yan-Zhi Liu; Tie-Fu Chen; Na Tang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

5.  Abuse in childhood and risk of uterine leiomyoma: the role of emotional support in biologic resilience.

Authors:  Renée Boynton-Jarrett; Janet W Rich-Edwards; Hee-Jin Jun; Eileen N Hibert; Rosalind J Wright
Journal:  Epidemiology       Date:  2011-01       Impact factor: 4.822

6.  Enhancing uterine fibroid research through utilization of biorepositories linked to electronic medical record data.

Authors:  Lani Feingold-Link; Todd L Edwards; Sarah Jones; Katherine E Hartmann; Digna R Velez Edwards
Journal:  J Womens Health (Larchmt)       Date:  2014-12       Impact factor: 2.681

Review 7.  Epidemiology of Uterine Fibroids: From Menarche to Menopause.

Authors:  Lauren A Wise; Shannon K Laughlin-Tommaso
Journal:  Clin Obstet Gynecol       Date:  2016-03       Impact factor: 2.190

8.  Genome-wide linkage and association analyses implicate FASN in predisposition to Uterine Leiomyomata.

Authors:  Stacey L Eggert; Karen L Huyck; Priya Somasundaram; Raghava Kavalla; Elizabeth A Stewart; Ake T Lu; Jodie N Painter; Grant W Montgomery; Sarah E Medland; Dale R Nyholt; Susan A Treloar; Krina T Zondervan; Andrew C Heath; Pamela A F Madden; Lynda Rose; Julie E Buring; Paul M Ridker; Daniel I Chasman; Nicholas G Martin; Rita M Cantor; Cynthia C Morton
Journal:  Am J Hum Genet       Date:  2012-10-05       Impact factor: 11.025

9.  Variants in BET1L and TNRC6B associate with increasing fibroid volume and fibroid type among European Americans.

Authors:  Todd L Edwards; Katherine E Hartmann; Digna R Velez Edwards
Journal:  Hum Genet       Date:  2013-07-28       Impact factor: 4.132

10.  Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.

Authors:  Bruce R Carr; Elizabeth A Stewart; David F Archer; Ayman Al-Hendy; Linda Bradley; Nelson B Watts; Michael P Diamond; Jingjing Gao; Charlotte D Owens; Kristof Chwalisz; W Rachel Duan; Ahmed M Soliman; Matthew B Dufek; James A Simon
Journal:  Obstet Gynecol       Date:  2018-11       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.